Age-correlated loss of dopaminergic binding sites in human basal ganglia

scientific article

Age-correlated loss of dopaminergic binding sites in human basal ganglia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1471-4159.1982.TB07996.X
P698PubMed publication ID7142992

P50authorBengt WinbladQ66000726
P2093author name stringFinch CE
Marcusson J
Severson JA
P2860cites workResolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regionsQ35355783
Dopamine receptor binding in inbred mice: strain differences in mesolimbic and nigrostriatal dopamine binding sitesQ35368949
Multiple receptors for dopamineQ37876912
Aging and Extrapyramidal FunctionQ39129889
Striatal lesions with kainic acid: neurochemical characteristicsQ39147642
Long-term sequelae of striatal kainate lesionQ39207491
Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigraQ39251718
Neurotransmitter Receptors in Frontal Cortex of SchizophrenicsQ39261348
Bilateral projections from precentral motor cortex to the putamen and other parts of the basal ganglia. An autoradiographic study in Macaca fascicularisQ39336189
Neurotransmitter receptor alterations in Parkinson's diseaseQ40093350
Cyclic AMP and cyclic GMP accumulation in vitro in brain regions of young, old and aged ratsQ40122596
Cells of origin and terminal distrubution of corticostriatal fibers arising in the sensory-motor cortex of monkeysQ41238210
Elevation of brain neuroleptic/dopamine receptors in schizophreniaQ41530785
Aging process affects a single class of dopamine receptorsQ41647482
3H-Spiperone binding in normal and schizophrenic post-mortem human brainQ41970620
Reduced dopaminergic binding during aging in the rodent striatumQ42242712
Evidence for selective loss of brain dopamine- and histamine-stimulated adenylate cyclase activities in rabbits with agingQ42472801
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlationsQ45302799
Age-related Changes in the Nigrostriatum: A Behavioral and Biochemical AnalysisQ48165086
Dopamine receptor binding of 3H-ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) regulated by guanyl nucleotidesQ48167713
An anatomy of schizophrenia?Q48642309
Age-related alterations in the rodent brain cholinergic system and behaviorQ52105726
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectdopamineQ170304
P304page(s)1623-1631
P577publication date1982-12-01
P1433published inJournal of NeurochemistryQ6295643
P1476titleAge-correlated loss of dopaminergic binding sites in human basal ganglia
P478volume39

Reverse relations

cites work (P2860)
Q44515489A post-mortem study on striatal dopamine receptors in Parkinson's disease
Q37889478ARAC--The Montreal Jewish General Hospital Alzheimer Risk Assessment Clinic
Q37735812Age and Parkinson's disease-related neuronal death in the substantia nigra pars compacta.
Q36533947Age and sex related differences in subcortical brain iron concentrations among healthy adults
Q33590439Age influences magnitude but not duration of response to levodopa
Q42447259Age-correlated changes in dopaminergic nigrostriatal perikarya of the C57BL/6NNia mouse
Q48131180Age-related Changes in the Nigrostriatal System
Q36730787Age-related changes in binding of the D2/3 receptor radioligand [(11)C](+)PHNO in healthy volunteers
Q67898218Age-related changes in human D1 dopamine receptors measured by positron emission tomography
Q30418974Age-related changes in signal transduction. Implications for neuronal transmission and potential for drug intervention
Q71345014Age-related decrease in responsiveness to L-DOPA is not due to changes in dopamine receptor mRNAs or G protein mRNAs
Q34627373Ageing and the nigrostriatal dopaminergic system
Q48222022Aging of the nigrostriatal pathway in humans
Q35732274Alzheimer's disease - not an exaggeration of healthy aging
Q44282697Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics
Q42518494Basal Ganglia Dopamine Receptor Autoradiography and Age-related Movement Disorders
Q36929398Behavioral and metabolic characterization of heterozygous and homozygous POLG mutator mice
Q34510415Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease
Q35223065Correlations of striatal dopamine synthesis with default network deactivations during working memory in younger adults
Q44237558D1and D2Dopamine Receptors in Human Substantia Nigra: Localization and the Effect of Aging
Q42208997Dihydroergocryptine improves behavioral deficits of aged male rats
Q46190328Disappearance of GAD-mRNA and tyrosine hydroxylase in substantia nigra following striatal ibotenic acid lesions: Evidence for transneuronal regression
Q45291180Dopamine D2 receptor SPECT imaging: basic in vivo characteristics and clinical applications of 123I-IBZM in humans
Q35631615Dopamine and frontostriatal networks in cognitive aging
Q39761733Dopamine and serotonin systems in human and rodent brain: effects of age and neurodegenerative disease
Q46322618Dopaminergic Changes in the Basal Ganglia A Generalized Phenomenon of Aging in Mammals
Q48229063Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine
Q36779439Drugs of abuse and the aging brain
Q34256020Effects of Age on Dopamine and Serotonin Receptors Measured by Positron Tomography in the Living Human Brain
Q41664306Effects of PPP1R1B (DARPP-32) Polymorphism on Feedback-Related Brain Potentials Across the Life Span
Q48680469Effects of clozapine and haloperidol on baseline levels of vacuous jaw movements in aged rats.
Q48541504Effects of morphine and aging on brain calmodulin levels in mice
Q86630273Functional and neurobiological similarities of aging in monkeys and humans
Q35612951Human serum Cohn fraction IV (alpha-globulin [correction of globin] enriched) inhibits ligand binding at neurotransmitter receptors in human brain
Q37404614Human striatal dopamine receptors are organized in compartments
Q41151744In vitro assessment of neurotrophic activity from the striatum of aging rats
Q33620597In vivo imaging of cerebral dopamine D3 receptors in alcoholism.
Q36254347Lack of age-dependent decrease in dopamine D3 receptor availability: a [(11)C]-(+)-PHNO and [(11)C]-raclopride positron emission tomography study
Q48361745Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy
Q39639357Neurodegenerative disorders and aging. Alzheimer's disease and Parkinson's disease--common ground
Q28201402Neuron-specific age-related decreases in dopamine receptor subtype mRNAs
Q43081301Neuroprotective effects of herbal ethanol extracts from Gynostemma pentaphyllum in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Q70180703Neurotransmitter Receptors and Aging
Q40079033Neurotransmitter receptors in the central nervous system and aging: Pharmacological aspect (review)
Q42471439Ontogeny of the electrophysiological activity of dopaminergic cells with special reference to the influence of adrenal medullary grafts on aging
Q69833378Opiate receptor characteristics in brains from young, mature and aged mice
Q45765813Pitfalls in membrane binding sites studies in post-mortem human brain
Q26865145Primate aging in the mammalian scheme: the puzzle of extreme variation in brain aging
Q42144670Prolonged P300 latency in children with the D2 dopamine receptor A1 allele.
Q48417560Quantitative imaging of neuroreceptors in the living human brain
Q47620139Recollection-related increases in functional connectivity across the healthy adult lifespan
Q39485807Regionally selective manifestations of neostriatal aging
Q33894630Relationship of striatal dopamine synthesis capacity to age and cognition
Q33627591Striatal dopamine D2 receptors in tardive dyskinesia: PET study
Q41278279Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels
Q39472243The ageing brain, neuroleptic drugs and the enigma of schizophrenia
Q35211789The ageing brain: normal and abnormal memory
Q39608202The neural basis of memory decline in aged monkeys

Search more.